DNMT3B and head and neck squamous cell carcinoma: DNMT3B, a DNA methyltransferase, is responsible for de novo DNA methylation and plays a crucial role as a potential prognostic biomarker and molecular therapeutic target in head and neck squamous cell carcinoma (HNSCC) (Yamaguchi et al., 2017; Goričan et al., 2023).